novel
virus
might
respons
numer
diseas
case
unknown
etiolog
studi
screen
nasopharyng
sampl
adult
outpati
respiratori
diseas
symptom
healthi
individu
employ
revers
transcript
rt
pcr
assay
codehopbas
primer
previous
develop
recogn
known
unknown
coronaand
torovirus
assay
detect
sampl
posit
human
coronavirus
hcov
includ
respiratori
tract
infect
rti
common
diseas
human
respons
signific
morbid
mortal
worldwid
especi
young
children
elderli
immunocompromis
individu
past
decad
grow
varieti
new
virus
implic
human
rti
includ
sever
acut
respiratori
syndrom
coronaviru
sarshcov
human
cov
hcov
human
metapneumoviru
hmpv
human
bocaviru
hbov
wu
ki
polyomavirus
wupyv
kipyv
respect
virus
belong
previous
unrecogn
speci
human
rhinoviru
c
hrvc
discoveri
facilit
advanc
diagnost
method
still
recent
conduct
studi
caus
agent
could
establish
respiratori
diseas
case
figur
indic
improv
current
diagnost
method
search
new
respiratori
virus
must
continu
main
challeng
identif
new
virus
unknown
characterist
one
popular
approach
succeed
use
either
degener
consensu
primer
recogn
highli
conserv
genom
region
alreadi
known
virus
primer
detect
new
pathogen
close
relat
member
establish
speci
identif
distantli
relat
unknown
virus
combin
consensu
degener
primer
design
strategi
implement
consensusdegener
hybrid
oligonucleotid
primer
codehop
techniqu
prove
superior
also
geneticbas
techniqu
sequenc
independ
develop
use
viru
discoveri
instanc
vidisca
method
base
recognit
restrict
enzym
cleavag
site
introduc
advanc
employ
nonrrna
hexam
random
prime
highthroughput
genom
sequenc
sampl
pool
use
centrifug
highli
sensit
unbias
sampl
abund
background
rnadna
may
suitabl
vidisca
process
remain
rel
limit
thu
codehopand
vidiscabas
techniqu
complementari
rather
altern
viru
discoveri
stage
technolog
develop
recent
describ
develop
valid
modifi
codehopbas
primer
design
recogn
distantli
relat
coronaand
torovirus
famili
coronavirida
revers
transcript
rt
pcr
assay
primer
detect
four
known
circul
human
coronavirus
two
bovin
torovirus
directli
biolog
specimen
addit
silico
predict
indic
design
primer
may
recogn
coronavirus
belong
recent
discov
lineag
result
demonstr
onestep
rtpcr
assay
suitabl
tool
identif
novel
member
famili
coronavirida
current
studi
present
result
first
largescal
applic
method
human
respiratori
specimen
collect
detect
four
current
known
coronavirus
provid
support
preval
respiratori
coronavirus
human
popul
total
nasopharyng
swab
collect
primarycar
network
base
antwerp
gent
rotenburg
utrecht
lodz
barcelona
mataro
jonkop
cardiff
southampton
seven
european
countri
belgium
germani
netherland
poland
spain
sweden
unit
kingdom
part
eu
framework
support
grace
genom
combat
resist
antibiot
communityacquir
lrti
europ
network
includ
studi
specimen
obtain
immunocompet
adult
outpati
year
age
respiratori
ill
asymptomat
match
control
three
consecut
winter
season
period
inclus
criteria
symptomat
patient
acut
cough
durat
includ
day
individu
gener
practition
suspect
presenc
acut
lower
respiratori
tract
infect
control
sampl
collect
practic
obtain
immunocompet
adult
sign
acut
respiratori
ill
gender
age
within
year
patient
age
younger
older
one
thousand
sixtyfour
sampl
collect
symptomat
adult
first
visit
gener
practition
sampl
followup
sampl
sampl
obtain
week
later
specimen
subject
without
respiratori
diseas
symptom
total
dnarna
nucleic
acid
extract
use
nuclisen
easymag
biomerieux
grenobl
franc
store
use
sampl
screen
inhous
monoplex
multiplex
realtim
rtpcr
assay
follow
respiratori
pathogen
human
rhinoviru
hrv
abc
parainfluenza
viru
piv
hmpv
adenoviru
hadv
hbov
respiratori
syncyti
viru
rsv
influenza
inf
ab
virus
wupyv
kipyv
addit
bacteri
infect
detect
well
partli
convent
cultur
also
molecular
method
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
bordetella
sp
streptococcu
pneumonia
haemophilu
spp
realtim
pcr
detect
hcov
viral
rna
reversetranscrib
cdna
use
multiscrib
revers
transcriptas
kit
random
hexam
appli
biosystem
foster
citi
ca
usa
accord
manufactur
guidelin
follow
inactiv
revers
transcriptas
min
hcov
typespecif
primer
probe
base
conserv
region
nucleocapsid
gene
tabl
suitabl
use
multiplex
assay
confirm
separ
test
exclud
crossinteract
sampl
assay
reaction
mixtur
contain
cdna
taqman
univers
pcr
master
mix
pe
appli
biosystem
primer
fluorogen
probe
label
report
dye
fam
quencher
dye
tamra
amplif
detect
perform
taqman
system
essenti
describ
elsewher
presenc
possibl
inhibitor
amplif
reaction
control
use
murin
encephalomyocard
viru
rna
phocin
herp
viru
dna
intern
control
coronaviru
identif
perform
retest
multiplex
realtim
pcr
posit
sampl
separ
typespecif
monoplex
primer
probe
set
interquartil
median
iqm
interquartil
rang
iqr
estim
obtain
spss
viru
discoveri
grace
sampl
analyz
blindli
pool
two
report
previous
brief
pool
rnadna
extract
contain
sampl
digest
dnase
use
dnase
amplif
grade
kit
life
technolog
breda
netherland
final
reaction
volum
follow
manufactur
instruct
rtpcr
assay
perform
use
qiagen
onestep
rtpcr
kit
qiagen
benelux
bv
venlo
netherland
final
volum
contain
lm
forward
lm
revers
primer
rna
sampl
amplif
carri
biorad
mycycl
biorad
veenenda
netherland
use
touchdown
thermocycl
protocol
describ
elsewher
pcr
product
analyz
tae
agaros
gel
stain
ethidium
bromid
amplif
product
expect
size
confirm
individu
retest
pool
sampl
use
rnadna
extract
origin
band
establish
sequenc
analysi
pcr
product
employ
multiplex
realtim
pcr
assay
design
detect
nasopharyng
specimen
found
posit
subsequ
type
use
speciesspecif
monoplex
assay
tabl
viral
load
specimen
contain
virus
differ
hcov
speci
compar
correspond
median
ct
valu
rang
parallel
screen
specimen
conduct
use
rtpcr
assay
search
new
member
famili
coronavirida
assay
amplifi
viru
sequenc
test
sampl
sampl
found
hcov
posit
realtim
pcr
assay
one
specimen
posit
viral
load
rel
high
character
median
interquartil
ct
valu
interquartil
rang
addit
rtpcr
assay
detect
three
sampl
posit
target
realtim
pcr
assay
bring
total
number
coronavirusposit
sampl
major
coronavirus
identifi
sampl
obtain
symptomat
patient
first
visit
gener
practition
detect
followup
sampl
asymptomat
control
rtpcr
assay
show
highest
sensit
toward
close
follow
infect
confirm
sampl
type
realtim
pcr
viral
load
correspond
ct
interquartil
rang
median
detect
rate
higher
median
interquartil
viral
load
correspond
ct
one
sampl
high
viru
load
ct
confirm
viral
load
posit
sampl
detect
rtpcr
assay
fals
neg
rel
low
interquartil
ct
valu
rang
median
falseneg
sampl
lower
median
interquartil
ct
valu
respect
comparison
indic
higher
viral
load
lower
sensit
assay
toward
result
accord
previou
find
use
quantifi
copi
rna
transcript
hcovposit
respiratori
specimen
goal
search
unknown
respiratori
human
coronavirus
distantli
relat
known
coronavirus
prototyp
new
genera
might
circul
human
popul
new
coronavirus
discov
studi
although
observ
neg
thu
belong
rare
report
document
import
unbias
knowledgebuild
studi
first
knowledg
larg
collect
sampl
screen
use
primer
set
design
recogn
coronaand
torovirus
rather
target
human
coronavirus
exclus
eg
see
ref
nonspecif
amplif
product
observ
analyz
specimen
includ
numer
sampl
posit
viru
pathogen
data
prepar
indic
rtpcr
assay
highli
select
respect
coronavirus
nasopharyng
sampl
lack
fals
posit
contribut
rel
high
tabl
speciesspecif
primer
probe
use
coronaviru
detect
multiplex
monoplex
pcr
assay
process
low
cost
assay
allow
us
analyz
larg
number
sampl
contrast
rate
fals
neg
consider
vari
differ
hcov
close
establish
pilot
studi
assay
introduc
falseneg
rate
detect
especi
lower
even
expens
increas
fals
posit
confid
lack
new
coronavirus
analyz
sampl
probabl
would
higher
unfortun
increas
primer
degeneraci
assay
control
sensit
practic
alreadi
high
due
enorm
evolutionari
distanc
coronavirus
torovirus
primer
design
cover
primer
design
done
accord
approach
minim
bia
respect
particular
subset
coronavirus
eg
hcov
thu
cover
genet
divers
evenli
valid
primer
confirm
silico
analysi
coronavirus
use
design
primer
thu
observ
falseneg
rate
obvious
high
viru
diagnost
standard
current
state
art
method
characterist
method
neg
conclus
new
respiratori
human
coronavirus
report
studi
restrict
pathogen
compar
preval
load
known
circul
respiratori
coronavirus
furthermor
acknowledg
conclus
may
also
depend
number
variabl
includ
limit
time
frame
popul
geograph
locat
survey
even
limit
believ
result
obtain
step
forward
character
natur
divers
human
coronavirus
studi
improv
method
expand
applic
assay
larger
dataset
also
includ
stool
cerebrospin
fluid
clinic
specimen
obtain
acut
diseas
case
unknown
etiolog
would
worth
explor
line
research
could
also
benefit
applic
virusdiscoveri
techniqu
involv
deep
nextgener
sequenc
eg
see
ref
